Rita Campanelli

ORCID: 0000-0003-4923-2761
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Eosinophilic Disorders and Syndromes
  • Chronic Myeloid Leukemia Treatments
  • Kruppel-like factors research
  • Acute Myeloid Leukemia Research
  • Platelet Disorders and Treatments
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • Angiogenesis and VEGF in Cancer
  • Multiple Myeloma Research and Treatments
  • Immune cells in cancer
  • Congenital Diaphragmatic Hernia Studies
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cell Adhesion Molecules Research
  • Mesenchymal stem cell research
  • Neonatal Respiratory Health Research
  • Vascular Malformations and Hemangiomas
  • Lymphatic System and Diseases
  • MicroRNA in disease regulation
  • Vascular Malformations Diagnosis and Treatment
  • Cytokine Signaling Pathways and Interactions
  • Erythropoietin and Anemia Treatment
  • Respiratory Support and Mechanisms
  • melanin and skin pigmentation

Policlinico San Matteo Fondazione
2012-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2015-2025

Foundation Center
2009-2022

University of Pavia
2013

MRC Epidemiology Unit
2013

University of Illinois Urbana-Champaign
2005

Illinois College
2005

NHS Blood and Transplant
2004

Fondazione Salvatore Maugeri
2000-2003

Christie's
2002

The new form of bronchopulmonary dysplasia (BPD) is characterized by lung immaturity with disrupted alveolar and capillary development after extremely premature birth, but the mechanism impaired vascular formation still not completely understood.We tested hypothesis that reduced numbers circulating endothelial progenitor cells at birth are associated BPD.We studied ninety-eight preterm infants gestational age less than 32 weeks or a weight 1,500 g. Endothelial colony-forming (ECFCs) were...

10.1164/rccm.200812-1949oc article EN American Journal of Respiratory and Critical Care Medicine 2009-07-03

Purpose In the WHO diagnostic classification, prefibrotic myelofibrosis (pre-MF) is included in category of primary (PMF). However, strong evidence for this position lacking. Patients and Methods We investigated whether pre-MF may be aligned along a clinical biological continuum 683 consecutive patients who received diagnosis PMF. Results As compared with PMF-fibrotic type, (132 cases) showed female dominance, younger age, higher hemoglobin, platelet count, lower white blood cell smaller...

10.1371/journal.pone.0035631 article EN cc-by PLoS ONE 2012-04-20

To identify epitopes on Escherichia coli heat-shock protein (HSP) dnaJ or homologous human HSP involved in the induction/modulation of autoimmune inflammation patients with oligoarticular juvenile idiopathic arthritis (JIA).We used a proliferation assay and cytokine production to evaluate immune responses synovial fluid mononuclear cells (SFMCs) pan-HLA-DR binder peptides derived from either nonhomologous regions bacterial dnaJ. Cytofluorometric analysis was performed order phenotype sort...

10.1002/art.22567 article EN Arthritis & Rheumatism 2007-04-27

Clonal endothelial progenitor cells (EPCs) have been implicated in the aberrant vascular growth that features infantile hemangioma (IH), most common benign tumor childhood may cause ulceration, bleeding, and/or permanent disfigurement. Endothelial colony-forming (ECFCs), truly EPCs endowed with clonal ability and capable of forming patent vessels vivo, remodel their Ca(2+) toolkit tumor-derived patients to acquire an adaptive advantage. Particularly, they upregulate proangiogenic...

10.1089/scd.2015.0240 article EN Stem Cells and Development 2015-12-10

Endothelial progenitor cells (EPCs) are present in circulation and contribute to vasculogenesis adults. We measured the number of circulating EPCs patients with myelofibrosis myeloid metaplasia (MMM), we examined relationship between severity MMM disease process.The was by assaying CD34+CD133+ vascular endothelial growth factor receptor 2 (VEGFR2) -positive cell phenotype 110 patients, 16 other Philadelphia-negative chronic myeloproliferative disorders (Ph-negative CMPDs), 14 healthy...

10.1200/jco.2005.09.021 article EN Journal of Clinical Oncology 2005-08-18

We studied plasma erythropoietin (EPO) levels and their relation with CD34+VEGFR-2+ (mature progenitor endothelial cells) CD34+ CD133+VEGFR-2+, or CD117+VEGFR-2+ (early/immature progenitors) cells in patients acute myocardial infarction (AMI). Fifty AMI undergoing percutaneous coronary intervention (PCI) within 6 h of symptom onset were enrolled. EPO, measured by ELISA, cell subsets, cytofluorimetric analysis, evaluated before PCI, 24 7 days afterwards. Forty-five healthy subjects (CTRLs)...

10.1093/eurheartj/ehm065 article EN European Heart Journal 2007-04-05

<title>Abstract</title> We report an in-depth retrospective analysis of updated series 30 subjects with clonal megakaryocyte dysplasia normal blood values (CMD-NBV). Sixteen were men, median age was 47.5 years (IQR, 39–53 years). A thrombosis-driven situational diagnosis (69% subjects), high incidence thrombotic events (6.5 x 100 subject-years), and indolent disease progression (one case only progressed towards active disease) the hallmarks CMD-NBV. Nineteen (63%) had a body mass index (BMI)...

10.21203/rs.3.rs-6622364/v1 preprint EN Research Square (Research Square) 2025-05-16

Megakaryocytes release platelets into the bloodstream by elongating proplatelets. In this study, we showed that human megakaryocytes constitutively Transforming Growth Factor β1 and express its receptors. Importantly, downstream signaling, through SMAD2/3 phosphorylation, was shown to be active in extending proplatelets, indicating a type of autocrine stimulation on megakaryocyte development. Furthermore, inactivation receptor inhibitors SB431542 Stemolecule ALK5 inhibitor, determined...

10.3324/haematol.2012.076752 article EN cc-by-nc Haematologica 2013-02-12

Neoangiogenesis is an integral component of bone marrow myeloproliferation in patients with myelofibrosis myeloid metaplasia (MMM). As extramedullary haematopoiesis a constitutive feature MMM, we studied spleen neoangiogenesis by computerized image analysis MMM patients. Compared five normal subjects, CD34-staining capillary vascular density (CVD) was 2.1-3.03 times higher than the upper range six 15 (40%) CD8-staining sinusoidal (SVD) constantly or lesser and inversely correlated CVD (R =...

10.1111/j.1365-2141.2004.04829.x article EN public-domain British Journal of Haematology 2004-02-02

Although there has been extensive analysis on the capacity of MHC–peptide tetramers to bind antigen-specific TCR, have comparatively few studies regarding role CD4 and CD8 co-receptors in binding activation by these multimeric molecules. Here, we start from observation that different antibodies against human exert opposite effects tetramer TCR: staining was enhanced OKT8 antibody, while it blocked with SK1 antibody. We used anti-CD8 modulate function during Melan-A/MART1-specific CTL clones....

10.1093/intimm/14.1.39 article EN International Immunology 2002-01-01
Coming Soon ...